Low dose cyclosporin A versus pulsed cyclophosphamide in Behcet's syndrome: a single masked trial.
Yılmaz Özyazgan(Access to Wholistic and Productive Living Institute), A Müftüoğlu(Istanbul University), Halit Pazarlı, Vedat Hamuryudan(Access to Wholistic and Productive Living Institute), Binnur Tüzün(Istanbul University-Cerrahpaşa), Hasan Yazıcı(Yazd University), Y Tüzün, Turgay Aktunç(Istanbul University-Cerrahpaşa), Sebahattin Yurdakul(Istanbul University)
Cited by 212
Related Papers
2018 update of the EULAR recommendations for the management of Behçet's syndrome
|Annals of the Rheumatic Diseases|2018|771
The Long-Term Mortality and Morbidity of Behçet Syndrome
|Medicine|2003|757
EULAR recommendations for the management of Behçet disease
|Annals of the Rheumatic Diseases|2008|721
A Controlled Trial of Azathioprine in Behçet's Syndrome
|New England Journal of Medicine|1990|646
Behçet syndrome: a contemporary view
|Nature Reviews Rheumatology|2018|438